Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae.

Froidure, Antoine [UCL] Mahsouli, Amin [UCL] Liistro, Giuseppe [UCL] De Greef, Julien [UCL] Belkhir, Leïla [UCL] Gerard, Ludovic [UCL] Bertrand, Aurélie [UCL] Koenig, Sandra [UCL] Pothen, Lucie [UCL] Yildiz, Halil [UCL] Mwenge, Gimbada Benny [UCL] Aboubakar Nana, Frank [UCL] Gohy, Sophie [UCL] Pilette, Charles [UCL] Reychler, Gregory [UCL] Coche, Emmanuel [UCL] Yombi, Jean Cyr [UCL] Ghaye, Benoît [UCL]

(eng) BACKGROUND: COVID-19 pandemic resulted in an unprecedented number of hospitalizations in general wards and intensive care units (ICU). Severe and critical COVID-19 patients suffer from extensive pneumonia; therefore, long-term respiratory sequelae may be expected. RESEARCH QUESTION: We conducted a cohort study to determine respiratory sequelae in patients with severe and critical COVID-19. We aimed at evaluating the proportion of patients with persisting respiratory symptoms and/or abnormalities in pulmonary function tests (PFT) or in lung imaging. STUDY DESIGN: and methods: This is a single center cohort study including COVID-19 survivors who underwent a three-month follow-up with clinical evaluation, PFT and lung high-resolution computed tomography (HRCT). All clinical, functional, and radiological data were centrally reviewed. Multiple linear regression analysis was performed to identify factors associated with residual lesions on HRCT. RESULTS: Full clinical evaluation, PFT and lung HRCT were available for central review in 126, 122 and 107 patients, respectively. At follow-up, 25% of patients complained from dyspnea and 35% from fatigue, lung diffusion capacity (DLCO) was decreased in 45%, 17% had HRCT abnormalities affecting more than 5% of their lung parenchyma while signs of fibrosis were found in 21%. In multiple linear regression model, number of days in ICU were related to the extent of persisting lesions on HRCT, while intubation was associated with signs of fibrosis at follow-up (P = 0.0005, Fisher's exact test). In contrast, the severity of lung imaging or PFT changes were not predictive of fatigue and dyspnea. INTERPRETATION: Although most hospitalized COVID-19 patients recover, a substantial proportion complains from persisting dyspnea and fatigue. Impairment of DLCO and signs suggestive of fibrosis are common but are not strictly related to long-lasting symptoms.